Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Polomar Health Services (PMHS) EPS (Weighted Average and Diluted) (2023 - 2025)

Polomar Health Services has reported EPS (Weighted Average and Diluted) over the past 3 years, most recently at -$0.02 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) fell 100.0% year-over-year to -$0.02; the TTM value through Sep 2025 reached -$0.09, down 125.0%, while the annual FY2024 figure was -$0.05, 150.0% down from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.02 at Polomar Health Services, roughly flat from -$0.02 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at -$0.0 in Q1 2023 and troughed at -$0.03 in Q4 2024.
  • A 3-year average of -$0.01 and a median of -$0.01 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 0.0% in 2024 and fell as far as 1150.0% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.01 in 2023, then crashed by 200.0% to -$0.03 in 2024, then soared by 33.33% to -$0.02 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for PMHS at -$0.02 in Q3 2025, -$0.02 in Q2 2025, and -$0.02 in Q1 2025.